SCHEMBL29403102

SCHEMBL29403102

CC(=O)OC1(C(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 6/20 0.72
CYP3A4 P08684 5/20 0.70
NR3C1 P04150 4/20 0.70
AR P10275 4/20 0.70
ABCB11 O95342 4/20 0.70
MAPT P10636 2/20 0.70
CYP2C19 P33261 2/20 0.70
CHRM2 P08172 2/20 0.70
CHRM1 P11229 2/20 0.70
ADORA3 P0DMS8 1/20 0.70
TBXA2R P21731 1/20 0.70
SLC6A2 P23975 1/20 0.70
ADRA1A P35348 1/20 0.70
MEN1 O00255 1/20 0.70
MAPK1 P28482 1/20 0.70
KMT2A Q03164 1/20 0.70
PDE4D Q08499 1/20 0.63
LMNA P02545 4/20 0.60
ALDH1A1 P00352 2/20 0.60
ESR1 P03372 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22400061 1.00 PGR (0.72) PGRCYP3A4NR3C1ARABCB11
SCHEMBL10951986 1.00 PGR (0.72) PGRCYP3A4NR3C1ARABCB11
SCHEMBL10954178 1.00 PGR (0.72) PGRCYP3A4NR3C1ARABCB11
SCHEMBL25334510 1.00 PGR (0.72) PGRCYP3A4NR3C1ARABCB11
SCHEMBL8853803 0.91 PGR (0.64) PGRCYP3A4NR3C1ARABCB11
SCHEMBL10890999 0.91 PGR (0.64) PGRCYP3A4NR3C1ARABCB11
SCHEMBL9618957 0.90 PGR (0.66) PGRCYP3A4NR3C1ARABCB11
SCHEMBL10891660 0.88 PGR (0.61) PGRCYP3A4NR3C1ARABCB11
SCHEMBL11599988 0.88 PGR (0.64) PGRCYP3A4NR3C1ARABCB11
SCHEMBL11408227 0.87 PGR (0.59) PGRCYP3A4NR3C1ARABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11274119-B2 Industrial process for the synthesis of nomegestrol-acetate RICHTER GEDEON NYRT. (HU) 2022-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11274119-B2 Industrial process for the synthesis of nomegestrol-acetate CYP19A1, HSD17B11, CYP17A1 PGR 29/4885CYP3A4 121/4885NR3C1 460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.